NASDAQ:ACER
Delisted
Acer Therapeutics Inc. Stock News
$0.660
+0 (+0%)
At Close: Feb 16, 2024
Best AMD Ryzen Black Friday Deals 2021: Top Early Ryzen 3, Ryzen 5, Ryzen 7 & Ryzen 9 CPU Savings Reviewed by Consumer Articles
12:40am, Sunday, 14'th Nov 2021 Kwhen FinanceAcer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation
08:30am, Thursday, 07'th Oct 2021
Notice of allowance of ACER-001 formulation composition of matter patent application strengthens proprietary position in U.S. until 2036 Notice of allowance of ACER-001 formulation composition of matt
FDA sets PDUFA target action date of June 5, 2022 FDA sets PDUFA target action date of June 5, 2022
Acer Therapeutics Stock Jumps As UCD Candidate Is Under FDA Review
07:21am, Wednesday, 06'th Oct 2021
The FDA has accepted for review Acer Therapeutics Inc (NASDAQ: ACER) and its partner, Relief Therapeutics Holding SA's (OTC: RLFTF) marketing application for ACER-001 (sodium phenylbutyrate) fo
ACER Stock: Why It Increased Today
07:03am, Wednesday, 06'th Oct 2021
The stock price of Acer Therapeutics Inc (NASDAQ: ACER) increased by over 15% pre-market today. This is why it happened.
Acer Therapeutics: Deriving Value By Developing Therapies For Rare Diseases
06:43pm, Tuesday, 31'st Aug 2021
Acer Therapeutics is a pharmaceutical company that acquires, develops and seeks to commercialize therapies for serious, rare, and life-threatening diseases. Acer submitted an NDA for its lead drug can
Acer Therapeutics to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
08:30am, Monday, 30'th Aug 2021
NEWTON, Mass., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious
Opexa Therapeutics, Inc. (ACER) Reports Q2 Loss, Misses Revenue Estimates
08:04pm, Tuesday, 10'th Aug 2021
Opexa Therapeutics, Inc. (ACER) delivered earnings and revenue surprises of 36.11% and -100.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the sto
NEWTON, Mass. and GENEVA, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER) (“Acer”), a pharmaceutical company focused on the acquisition, development and commercialization o
ACER Stock Increases Over 20% Pre-Market: Why It Happened
08:20am, Thursday, 29'th Jul 2021
The stock price of Acer Therapeutics Inc (NASDAQ: ACER) increased by over 20% pre-market. This is why it happened.
4 Small Drug Stocks Set to Escape the COVID-Led Industry Weakness
11:17am, Monday, 21'st Jun 2021
4 Small Drug Stocks Set to Escape the COVID-Led Industry Weakness
Acer Therapeutics Plans Clinical Trial for EDSIVO™ (celiprolol) Following Type B FDA Meeting
08:30am, Thursday, 10'th Jun 2021
Phase 3, randomized, double-blind, placebo-controlled, decentralized clinical trial estimated to take approximately 3.5 years to complete once fully enrolled
Notice of Settlement of Derivative Suits
04:05pm, Thursday, 25'th Mar 2021
NEWTON, Mass., March 25, 2021 (GLOBE NEWSWIRE) -- IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MASSACHUSETTS
ACER Stock Price Increases Over 30% Pre-Market: Why It Happened
06:24am, Monday, 22'nd Mar 2021
The stock price of Acer Therapeutics Inc (NASDAQ: ACER) has increased by over 30% pre-market. This is why it happened.
ACER Stock: The Merger Rumor That Has Acer Therapeutics Racing Higher
11:02am, Monday, 15'th Mar 2021
Acer Therapeutics (ACER) stock is on the rise Monday as investors speculate about a possible merger with Relief Therapeutics. The post ACER Stock: The Merger Rumor That Has Acer Therapeutics Racing Hi
